Clin Nutr Res.  2017 Jul;6(3):161-171. 10.7762/cnr.2017.6.3.161.

Risk Factors for Breast Cancer in Gaza Strip, Palestine: a Case-Control Study

• Kariri M
• Jalambo MO
• Kanou B
• Deqes S
• Younis S
• Zabut B
• Balawi U

• KMID: 2385621
• DOI: http://doi.org/10.7762/cnr.2017.6.3.161

Abstract

Breast cancer (BC) is the main common cause of cancer mortality among women in the world. This study aims at investigating BC epidemiology and identifying the different risk factors associated and the most affecting ones among women in the Gaza Strip, Palestine. This study was a hospital-based case-control (1:2), as the study was carried out over the period of October 2014 to February 2015. A total of 105 BC patients, chosen from Al-Shifa Hospital in Gaza City and European hospital for the south governorate, were the case and compared to 209 women as a control group who matched the cases in age, residence, and with no history of breast problems. The age of the enrolled cases and controlled ranged between 18 to 60 years. The face-to-face interview was conducted during the patient visit to the oncology department and the control visit in their home. The result illustrated that women who had late pregnancy (> 35 years) (odds ratio [OR], 11.56; 95% confidence interval [CI], 1.64-81.35), or high body mass index (BMI; ≥ 30 kg/m²) (OR, 4.70; 95% CI, 1.62-13.69), or first-degree family history of BC (OR, 2.7; 95% CI, 1.04-7.20), or hypertensive patients (OR, 12.13; 95% CI, 1.93-76.10), or diabetic (OR, 6.84; 95% CI, 1.77-26.36) were more likely to have increased BC risk. The findings of the present study suggest that positive family history of BC, high BMI, and some common diseases (hypertension, diabetes mellitus) may be the epigenetic factors promoting the occurrence of BC.

Keyword

Breast cancer; Women; Risk factors; Gaza

MeSH Terms

Body Mass Index
Breast Neoplasms*
Breast*
Case-Control Studies*
Epidemiology
Epigenomics
Female
Humans
Middle East*
Mortality
Pregnancy
Risk Factors*

Reference

1. Naieni KH, Ardalan A, Mahmoodi M, Motevalian A, Yahyapoor Y, Yazdizadeh B. Risk factors of breast cancer in north of Iran: a case-control in Mazandaran Province. Asian Pac J Cancer Prev. 2007; 8:395–398.

2. Phillips KA, Steel EJ, Collins I, Emery J, Pirotta M, Mann GB, Butow P, Hopper JL, Trainer A, Moreton J, Antoniou AC, Cuzick J, Keogh L. Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease? Aust J Prim Health. 2016; 22:255–261.

3. Aleksoska K. Macedonian women and breast cancer: a model of psychosocial support for early detection and treatment. Aust J Prim Health. 2005; 11:63–71.

4. Minister of Health of the Palestinian National Authority. Registry Pc. Gaza: Minister of Health of the Palestinian National Authority;2014.

5. Minister of Health of the Palestinian National Authority. Monitoring and follow-up of cancer patients [Internet]. Gaza: Minister of Health of the Palestinian National Authority;2016. 2016 November 15. Available from: http://www.moh.gov.ps/portal/.

6. Darweesh A. Risk factors of breast cancer among Palestinian women in North West Bank [master's thesis]. Nablus: Al-Najah National University;2009.

7. Meshram II, Hiwarkar PA, Kulkarni PN. Reproductive risk factors for breast cancer: a case control study. Online J Health Allied Sci. 2009; 8:5.

8. El Shamaa ET, Hassanein MH. Risk factors of breast cancer in abha city: a case control study. Acad Res Int. 2012; 2:34–41.

9. Stewart BW, Kleihues P. World cancer report. Lyon: IARC Press;2003.

10. Shamseddine A, Sibai AM, Gehchan N, Rahal B, El-Saghir N, Ghosn M, Aftimos G, Chamsuddine N, Seoud M; Lebanese Cancer Epidemiology Group. Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998. Ann Epidemiol. 2004; 14:663–668.

11. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001; 358:1389–1399.

12. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol. 2001; 2:133–140.

13. Gilliland FD, Hunt WC, Baumgartner KB, Crumley D, Nicholson CS, Fetherolf J, Samet JM. Reproductive risk factors for breast cancer in Hispanic and non-Hispanic white women: the New Mexico Women's Health Study. Am J Epidemiol. 1998; 148:683–692.

14. Tavani A, Gallus S, La Vecchia C, Negri E, Montella M, Dal Maso L, Franceschi S. Risk factors for breast cancer in women under 40 years. Eur J Cancer. 1999; 35:1361–1367.

15. Kuru B, Ozaslan C, Ozdemir P, Dinç S, Camlibel M, Alagöl H. Risk factors for breast cancer in Turkish women with early pregnancies and long-lasting lactation--a case-control study. Acta Oncol. 2002; 41:556–561.

16. Oran B, Celik I, Erman M, Baltali E, Zengin N, Demirkazik F, Tezcan S. Analysis of menstrual, reproductive, and life-style factors for breast cancer risk in Turkish women: a case-control study. Med Oncol. 2004; 21:31–40.

17. Yang PS, Yang TL, Liu CL, Wu CW, Shen CY. A case-control study of breast cancer in Taiwan--a low-incidence area. Br J Cancer. 1997; 75:752–756.

18. Ebrahimi M, Vahdaninia M, Montazeri A. Risk factors for breast cancer in Iran: a case-control study. Breast Cancer Res. 2002; 4:R10.

19. Bhadoria AS, Kapil U, Sareen N, Singh P. Reproductive factors and breast cancer: a case-control study in tertiary care hospital of North India. Indian J Cancer. 2013; 50:316–321.

20. Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE Jr, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Key TJ, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR, Longcope C; Endogenous Hormones Breast Cancer Collaborative Group. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003; 95:1218–1226.

21. Norsa’adah B, Rusli BN, Imran AK, Naing I, Winn T. Risk factors of breast cancer in women in Kelantan, Malaysia. Singapore Med J. 2005; 46:698–705.

22. Ozmen V, Ozcinar B, Karanlik H, Cabioglu N, Tukenmez M, Disci R, Ozmen T, Igci A, Muslumanoglu M, Kecer M, Soran A. Breast cancer risk factors in Turkish women--a University Hospital based nested case control study. World J Surg Oncol. 2009; 7:37.

23. Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L. Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women. Int J Cancer. 2003; 106:96–102.

24. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007; 121:856–862.

25. Abdeen H. Chronic diseases in Palestine: the rising tide. Bridges. 2006; 2:4–7.

26. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, la Vecchia C. Hypertension and hormone-related neoplasms in women. Hypertension. 1999; 34:320–325.

27. Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N, Peel D, Anton-Culver H. Hypertension, diuretics and breast cancer risk. J Hum Hypertens. 2006; 20:727–732.

28. Kabat GC, Kim M, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, Neuhouser ML, Parker DR, Shikany JM, Stefanick ML, Thomson CA, Rohan TE. A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2009; 18:2046–2053.

29. Rosato V, Bosetti C, Talamini R, Levi F, Montella M, Giacosa A, Negri E, La Vecchia C. Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol. 2011; 22:2687–2692.

30. Lindgren A, Pukkala E, Tuomilehto J, Nissinen A. Incidence of breast cancer among postmenopausal, hypertensive women. Int J Cancer. 2007; 121:641–644.

31. Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, Krogh V. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis. 2010; 20:41–48.

32. Bjørge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Häggström C, Stattin P, Engeland A. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev. 2010; 19:1737–1745.

33. Reeves KW, McLaughlin V, Fredman L, Ensrud K, Cauley JA. Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort. Cancer Causes Control. 2012; 23:1241–1251.

34. Franceschi S, la Vecchia C, Negri E, Parazzini F, Boyle P. Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer. 1990; 26:781–785.

35. La Vecchia C, Negri E, Franceschi S, Talamini R, Bruzzi P, Palli D, Decarli A. Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer. 1997; 75:441–444.

36. National Cancer Institute (US). Reproductive history and cancer risk [Internet]. Bethesda (MD): National Cancer Institute;2011. cited 2016 January 8. Available from: http://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/reproductive-history-fact-sheet.

37. Nee PW. The key facts on cancer risk factors and causes: the key facts on cancer volumn III. Boston (MA): MedicalCenter.com;2013.

38. Wohlfahrt J, Melbye M. Age at any birth is associated with breast cancer risk. Epidemiology. 2001; 12:68–73.

39. Hall IJ, Moorman PG, Millikan RC, Newman B. Comparative analysis of breast cancer risk factors among African-American women and White women. Am J Epidemiol. 2005; 161:40–51.

40. Jatoi I, Anderson WF. Qualitative age interactions in breast cancer studies: a mini-review. Future Oncol. 2010; 6:1781–1788.

41. Butt Z, Haider SF, Arif S, Khan MR, Ashfaq U, Shahbaz U, Bukhari MH. Breast cancer risk factors: a comparison between pre-menopausal and post-menopausal women. J Pak Med Assoc. 2012; 62:120–124.

42. Opdahl S, Alsaker MD, Janszky I, Romundstad PR, Vatten LJ. Joint effects of nulliparity and other breast cancer risk factors. Br J Cancer. 2011; 105:731–736.

43. Garland M, Hunter DJ, Colditz GA, Manson JE, Stampfer MJ, Spiegelman D, Speizer F, Willett WC. Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women. Am J Epidemiol. 1998; 147:636–643.

44. Iwasaki M, Otani T, Inoue M, Sasazuki S, Tsugane S; Japan Public Health Center-based Prospective Study Group. Role and impact of menstrual and reproductive factors on breast cancer risk in Japan. Eur J Cancer Prev. 2007; 16:116–123.

45. Hadjisavvas A, Loizidou MA, Middleton N, Michael T, Papachristoforou R, Kakouri E, Daniel M, Papadopoulos P, Malas S, Marcou Y, Kyriacou K. An investigation of breast cancer risk factors in Cyprus: a case control study. BMC Cancer. 2010; 10:447.

46. Apter D, Vihko R. Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J Clin Endocrinol Metab. 1983; 57:82–86.